A novel genomic inversion in Wiskott-Aldrich-associated autoinflammation.Advances in gene therapy for ADA-deficient SCID.Clinical applications of gene therapy for primary immunodeficienciesFirst Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature.Gene therapy for adenosine-deaminase-deficient severe combined immunodeficiency.Gene therapy for adenosine deaminase deficiencyGene therapy for adenosine deaminase deficiencyGene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I.Gene therapy for Wiskott-Aldrich Syndrome.Lentiviral vectors for the treatment of primary immunodeficienciesManagement options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006).Pioglitazone as a novel therapeutic approach in chronic granulomatous disease.Progress in gene therapy for primary immunodeficiencies using lentiviral vectors.Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndromeRetroviral integrations in gene therapy trialsTen years of gene therapy for primary immune deficiencies.The role of conditioning in hematopoietic stem cell gene therapy.
author
gender
sameAs
K-3918-2016
worksFor
type
comment
researcher
@en
researcher
@en-gb
wetenschapper
@nl
дослідник
@uk
հետազոտող
@hy
研究者
@ja
研究者
@zh
연구원
@ko
label
Alessandro Aiuti
@ast
Alessandro Aiuti
@en
Alessandro Aiuti
@en-gb
Alessandro Aiuti
@es
Alessandro Aiuti
@it
Alessandro Aiuti
@nl
Alessandro Aiuti
@sl